Corona research: Consortium of Berlin research and industry seeks active ingredients
Protein crystals are analysed in the MX laboratory at BESSY II with hard X-rays. © C. Feiler/HZB
At BESSY II, Prof. Rolf Hilgenfeld (Uni Lübeck) was able to analyse an important protein of the SARS-CoV2 virus, the viral main protease which enables the virus to multiply. © H.Tabermann/HZB
The Berlin biotech company Molox GmbH and a team at the Helmholtz-Zentrum Berlin (HZB) have initiated a consortium of regional research groups and BASF. Together, they want to identify a starting point for the development of a potential active substance against the new coronavirus. Targets of potential inhibitors will be SARS-CoV2 proteins that promote the spread or infectivity of the viruses. Scientists from Freie Universität Berlin are also involved in the research work.
"Berlin combines important large-scale infrastructure with an excellent network of academic and industrial structural biologists and biochemists. The distances here are short, but resources and expertise must be strategically coordinated to be successful," says Dr. Holger von Moeller, the owner of the biotech company Molox.
Access to synchrotron radiation is essential for the success of the project. This particularly intense radiation is provided by the Berlin Electron Storage Ring for Synchrotron Radiation (BESSY II), which is operated by the HZB.
Several research groups at Freie Universität Berlin led by Prof. Markus Wahl, Prof. Christian Freund, Dr. Ursula Neu, and Prof. Sutapa Chakrabarti are working with Molox to produce the proteins and then crystallize them.
"The HZB is making all existing infrastructures available to the joint project," explains Dr. Manfred Weiss, head of the Research Group Macromolecular Crystallography (MX) at HZB.
BASF is the first project partner from the chemical industry to provide funds to start the investigations. Protein crystals will be saturated with potential inhibitors and subsequently analysed on the MX beamlines of BESSY II. In this way it can be discovered which compounds are particularly good at inhibiting the function of the protein - these should then be the starting points for the development of active substances.
The consortium is currently negotiating with other partners in order to acquire them and their substance libraries. "We are looking forward to this joint project and hope that we will be able to identify new potential active substances against SARS-CoV-2 very quickly", says Dr. Christian Feiler, project leader at HZB.
- Freeze casting - a guide to creating hierarchically structured materialsFreeze casting is an elegant, cost-effective manufacturing technique to produce highly porous materials with custom-designed hierarchical architectures, well-defined pore orientation, and multifunctional surface structures. Freeze-cast materials are suitable for many applications, from biomedicine to environmental engineering and energy technologies. An article in "Nature Reviews Methods Primer" now provides a guide to freeze-casting methods that includes an overview on current and future applications and highlights characterization techniques with a focus on X-ray tomoscopy.
- IRIS beamline at BESSY II extended with nanomicroscopyThe IRIS infrared beamline at the BESSY II storage ring now offers a fourth option for characterising materials, cells and even molecules on different length scales. The team has extended the IRIS beamline with an end station for nanospectroscopy and nanoimaging that enables spatial resolutions down to below 30 nanometres. The instrument is also available to external user groups.
- A simpler way to inorganic perovskite solar cellsInorganic perovskite solar cells made of CsPbI3 are stable over the long term and achieve good efficiencies. A team led by Prof. Antonio Abate has now analysed surfaces and interfaces of CsPbI3 films, produced under different conditions, at BESSY II. The results show that annealing in ambient air does not have an adverse effect on the optoelectronic properties of the semiconductor film, but actually results in fewer defects. This could further simplify the mass production of inorganic perovskite solar cells.